How can we address—and solve—2 of the biggest hurdles for patients in receiving mental health care?
Psychiatric Times’ Substance Use Section Editor weighs in on the FDA approval of the first naloxone product for nonprescription use.
How can you be better prepared to interview and care for peripartum patients? This CME shows you how.
What treatment strategies are available to improve the quality of life for older adults who are aging with schizophrenia?
"Our own implicit biases come into play at times whether we like it or not, especially when it comes to frequently controversial medications."
How can we face the current pandemic while addressing the brain health crisis?
A patient, faced with a lung cancer diagnosis and the fear of death, goes through the stages of grief. How can you as clinicians lead them through?
What sleep disorders are common in older adults and what are the associated risk factors and correlates?
The American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.
Children with autism spectrum disorder have special educational needs, but with proper guidance they can flourish, even during a pandemic.
This moment in history cannot be lost. When you ask us if we are okay, be prepared to hear us say we are not . . . and never have been. Then be prepared to do more.
Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
A diverse group of psychiatrists elaborates on the difficult conversation surrounding reparations, and why our society needs to pay attention.
Often misdiagnosed as other psychiatric disorders, FTD is the third most common type of dementia and the second most common among patients 65 years or younger. How to spot the signs.
“I have found that community involvement is really key to a sense of belonging and really feeding our soul as we think about maintaining our mental health.”
"CT-R emphasizes the importance of hope while taking it a step further, turning hope into meaningful action and internalizing what success says about a person’s identity, strength, and ability to navigate future challenges."
What are the challenges and opportunities for improvement in COVID-19-related mental health care?
Drs Stephen Faraone, Theresa Cerulli, Craig Chepke, and Andrew J. Cutler discuss novel drug delivery systems and provide take-home messages when treating an adult with ADHD.
Instead of figuring out ways to help people die, what if we devoted our energy to helping them live, even and especially if they are dying?
How can a robust understanding of the altered-state experience drive the development of therapeutic frameworks that are designed around that experience?
The key to addressing mental health may lie in business innovation theories.
This new study is evaluating how effective psychedelics can be in the treatment of binge eating disorder.
COVID-19 has made treating patients who receive long-acting injectables complicated. The Chief Medical Officer of Houston Behavioral Healthcare Hospital offers suggestions on how best to proceed.
Psychiatric disorders affect 1 in 3 individuals with epilepsy—and their etiology is multifactorial.
Tips for helping patients preserve their sobriety through the holiday season
Why does the prospect of getting back to normal after the pandemic disturb some patients? And what can be done to overcome these fears?
Violence against women and resulting traumatic brain injuries increased during the COVID-19 pandemic.